2) Prulifloxacin
普利沙星
1.
Spectroscopic Studies on the Binding of Prulifloxacin and ct-DNA;
光谱法研究普利沙星与小牛胸腺DNA的结合作用
2.
The binding among Co(phen)~(2+)_3,prulifloxacin and calf thymus DNA in Tris buffer solution(pH=7.
利用电化学和紫外光谱法研究了邻菲咯啉合钴(Co(phen)32+)与普利沙星(PLFX)及DNA间在pH=7。
3.
After absorption, prulifloxacin is metabolised by esterases to ulifloxacin, which inhibits the formation of superhelix, cell division and reproduction by interfering the DNA toposomerase.
普利沙星是新口服的氟喹诺酮类抗菌药。
3) prulifloxacin
普卢利沙星
1.
Study on Bioequiavailability of Prulifloxacin Capsules in Human Bodies;
普卢利沙星胶囊的人体生物等效性研究
2.
Determination of Main Pharmaceutical Ingredient in Prulifloxacin Tablets by Ultraviolet Spectrophotometry;
紫外分光光度法测定普卢利沙星片中主药的含量
3.
Evaluation for the active metabolites and pharmacokinetics of prulifloxacin in Chinese healthy volunteers;
血浆普卢利沙星活性代谢物的测定及其人体药动学研究
4) Prulifloxacin tablet
普利沙星片
1.
To determine the content of Prulifloxacin tablet by HPLC,this method shows a good precision,accuracy and repetition.
目的 建立普利沙星片的含量测定方法。
5) Prulifloxacin capsule
普卢利沙星胶囊
1.
Objective:To optimize the best formulation technique of Prulifloxacin capsule.
目的:筛选普卢利沙星胶囊的最佳处方组成。
6) prulifloxacin tablet
普卢利沙星片
1.
Pharmacokinetics of prulifloxacin tablets in Chinese healthy volunteers;
普卢利沙星片在健康人体的药代动力学
补充资料：普卢利沙星
分子式：C21H20FN3O6S
分子量：461.46
CAS号：123447-62-1
性质：
分子量：461.46
CAS号：123447-62-1
性质：
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条